AHF Receives Expedited Florida Hearing Opposing ADAP Reductions

Group sued Florida DOH over rules cutting lifesaving HIV/AIDS treatment for thousands FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Today, AIDS Healthcare Foundation (AHF) asked for and received an expedited hearing schedule in its legal efforts to block harmful changes to Florida’s AIDS Drug Assistance Plan (ADAP). It is estimated that 16,000 Floridians living with HIV/AIDS could lose access … [Read more…]

The Cannabist Company Enters Into Forbearance Agreement With Senior Secured Noteholders

CHELMSFORD, Mass.–(BUSINESS WIRE)–The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or “the Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the United States, today announced that it has entered into a forbearance agreement (the “Forbearance Agreement”), with an ad hoc group of noteholders (the … [Read more…]

Amtelco Celebrates 50 Years of Pioneering Innovation in the Communications Industry

Amtelco proudly celebrates its 50th anniversary this year, commemorating five decades of invention, growth, and commitment to the call center industry. MCFARLAND, Wis.–(BUSINESS WIRE)–#AI–Amtelco, a leader in the call center industry, announced it is celebrating its 50th anniversary, recognizing half a century of commitment to providing innovative communication tools and software built on tradition. This … [Read more…]

GLP-1 Analogues Market Research 2025: Increasing Diabetes and Obesity Rates and a Strong R&D Pipeline Support Market Expansion – Forecast to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “GLP-1 Analogues Market” report has been added to ResearchAndMarkets.com’s offering. This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. … [Read more…]

Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 being held from February 11-12, 2026 in New … [Read more…]

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability PARIS–(BUSINESS WIRE)–Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of … [Read more…]

Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity

Results from a global survey of over 4,300 women across five continents presented at IMCAS 2026 reveal a knowledge gap on the impact of menopause on the skin, despite women experiencing around three skin changes during menopause1 Galderma will also host a symposium delving into the challenges and science behind menopause-related skin changes and aesthetic … [Read more…]

Gilad&Gilad Launches AgmaVet® For Horses for Promoting Resilient Nerve Functions and Joints Mobility

LAS VEGAS–(BUSINESS WIRE)–From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine®, Gilad&Gilad is excited to announce the launch of AgmaVet® For Horses, a new product dedicated to promoting resilient nerve functions and alleviate joints discomfort. Osteoarticular (OA), or joints, health deterioration is very common in animals, as it is in humans. … [Read more…]

OSI Systems Reports Fiscal 2026 Second Quarter Financial Results

Record Q2 Revenues of $464 Million (11% year-over-year growth) Q2 Earnings per Diluted Share GAAP EPS of $2.22 Record Non-GAAP EPS of $2.58 Q2 Operating Cash Flow of $62 Million Company Increases Fiscal 2026 Non-GAAP EPS Guidance HAWTHORNE, Calif.–(BUSINESS WIRE)–OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for … [Read more…]

Global Healthy Living Foundation Study Shows Influenza Cost the U.S. Economy Nearly $29 Billion in 2023-2024 Flu Season

Higher Adult Vaccination Could Have Prevented Tens of Thousands of Deaths UPPER NYACK, N.Y.–(BUSINESS WIRE)–A Global Healthy Living Foundation (GHLF) study showed seasonal influenza continues to impose a massive and largely preventable economic and human toll on the United States. According to the newly released paper, “Influenza’s Economic Burden and the Impact of Adult Vaccination,” … [Read more…]